<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1310222730
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1986
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        TRIMOL SUSP
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        SULFAMETHOXAZOLE,TRIMETHOPRIM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        40,8
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Syrup
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        8.55
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01EE01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>TRIMOL</strong> Paediatric 40mg/200mg per 5mL Oral Suspension is a combination of two different antibiotics called sulphamethoxazole and trimethoprim, which is used to treat infections caused by bacteria. This medicine combination is also named as co-trimoxazole. Like all antibiotics, <strong>TRIMOL</strong> only works against some types of bacteria. This means that it is only suitable for treating some types of infections.&nbsp;</p><p><strong>TRIMOL</strong> can be used to treat or prevent:&nbsp;</p><p>&sect; Lung infections (pneumonia) caused by the micro-organism, <em>Pneumocystis jirovecii </em>(previously known as <em>Pneumocystis carinii</em>) (some people call this &lsquo;PJP&rsquo;).</p><p><strong>TRIMOL</strong> can be used to treat:&nbsp;</p><p>&sect; Urinary bladder or urinary tract infections (water infections).</p><p>&sect; Respiratory tract infections such as bronchitis.</p><p>&sect; Ear infections such as otitis media.</p><p>&sect; An infection called nocardiosis which can affect the lungs, skin and brain.</p><p>&sect; An infection caused by a bacteria called toxoplasma (toxoplasmosis).</p><p>&sect; An infection called brucellosis, if other treatments were not effective and in combination with other agents in line with national treatment guidelines.</p><p>Consideration should be given of official guidance on the appropriate use of antibacterial agents.</p><p><strong>TRIMOL</strong> Paediatric Suspension is indicated in children aged 12 years and under (infants (&gt;6 weeks to &lt;2 years old) and children (&gt;2 to &lt;12 years old).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Your child should not take TRIMOL</strong> <strong>if: </strong></p><p>&sect; They are allergic to the active substance(s) sulphamethoxazole, trimethoprim, co-trimoxazole or any of the other ingredients of this medicine (listed in section 6).</p><p>&sect; They are allergic to sulphonamide medicines. Examples include sulphonylureas (such as gliclazide and glibenclamide) or thiazide diuretics (such as bendroflumethiazide&ndash;a water tablet).</p><p>&sect; They have severe liver or severe kidney problems.</p><p>&sect; They have ever had a problem with their blood causing bruises or bleeding (thrombocytopenia).</p><p>&sect; You have been told that your child have a rare blood problem called porphyria, which can affect their skin or nervous system. &nbsp;</p><p>&sect; <strong>TRIMOL</strong> should not be given to infants during the first 6 weeks of life</p><p>If you are not sure if any of the above apply to your child, talk to their doctor or pharmacist before they take <strong>TRIMOL</strong>.&nbsp;</p><p><strong>Warnings and precautions&nbsp;&nbsp; </strong></p><p>Potentially life-threatening skin rashes (Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported with the use of co-trimoxazole appearing initially as reddish target-like spots or circular patches often with central blisters on the trunk. Additional signs to look for include ulcers in the mouth, throat, nose, genitals and conjunctivitis (red and swollen eyes). These potentially life-threatening skin rashes are often accompanied by flu-like symptoms. The rash may progress to widespread blistering or peeling of the skin. The highest risk for occurrence of serious skin reactions is within the first weeks of treatment.&nbsp;&nbsp;</p><p>If your child has developed Stevens-Johnson syndrome or toxic epidermal necrolysis with the use of co-trimoxazole your child must not be re-started on co-trimoxazole at any time. If your child develops a rash or these skin symptoms, stop giving co-trimoxazole, seek urgent advice from a doctor and tell him that your child is taking this medicine.</p><p>Talk to your child&rsquo;s doctor or pharmacist before taking <strong>TRIMOL</strong> if:&nbsp;&nbsp;</p><p>&sect; They have severe allergies or bronchial asthma.</p><p>&sect; You have been told that your child is at risk for a rare blood disorder called porphyria.</p><p>&sect; They don&rsquo;t have enough folic acid (a vitamin) in their body - which can make their skin pale and make them feel tired, weak and breathless. This is known as anaemia.</p><p>&sect; They have a disease called glucose-6-phosphate dehydrogenase deficiency, which can cause jaundice or spontaneous destruction of red blood cells.</p><p>&sect; They have a problem with their metabolism called phenylketonuria and are not on a special diet to help their condition.</p><p>&sect; They are underweight or malnourished.</p><p>&sect; You have been told by your child&rsquo;s doctor that your child has a lot of potassium in their blood or if your child takes medicines that can increase the amount of potassium in your child&rsquo;s blood, such as diuretics (water tablets, which help increase the amount of urine you produce) steroids (like prednisolone) and digoxin. High levels of potassium in your child&rsquo;s blood, can cause abnormal heart beats (palpitations), nausea, dizziness or headache.</p><p>&sect; You have been told by your child&rsquo;s doctor that your child has an abnormally low level of sodium in their blood.</p><p>&sect; You have been told by your child&rsquo;s doctor that your child has any serious disorders of the blood and blood forming tissues (haematological disorders). E.g. low blood cell counts.</p><p>&sect; They have a kidney disease.</p><p><strong>Other medicines and TRIMOL </strong></p><p>Tell your child&rsquo;s doctor or pharmacist if your child is taking, has recently taken or might take any other medicines. This is because <strong>TRIMOL</strong> can affect the way some medicines work. Also some other medicines can affect the way <strong>TRIMOL</strong> works.&nbsp;&nbsp;</p><p>In particular tell your child&rsquo;s doctor of pharmacist if your child is taking any of the following medicines:</p><p>&sect; Diuretics (water tablets), which help increase the amount of urine produced.</p><p>&sect; Pyrimethamine, used to treat and prevent malaria, and to treat diarrhoea.</p><p>&sect; Ciclosporin, used after organ transplant surgeries.</p><p>&sect; Blood thinners such as warfarin.</p><p>&sect; Phenytoin, used to treat epilepsy (fits).</p><p>&sect; Medicines used to treat diabetes, such as glibenclamide, glipizide or tolbutamide (sulphonylureas) and repaglinide.</p><p>&sect; Medicines to treat problems with the way the heart beats such as digoxin or procainamide.</p><p>&sect; Amantadine, used to treat Parkinson&rsquo;s disease, multiple sclerosis, flu or shingles.</p><p>&sect; Medicines to treat HIV (Human Immunodeficiency Virus), called zidovudine or lamivudine.</p><p>&sect; Medicines that can increase the amount of potassium in the blood, such as diuretics (water tablets, which help increase the amount of urine produced such as spironolactone), steroids (like prednisolone) and digoxin.</p><p>&sect; Azathioprine, may be used in patients following organ transplant or to treat immune system disorders or inflammatory bowel disease</p><p>&sect; Methotrexate, a medicine used to treat certain cancers or certain diseases affecting the immune system.</p><p>&sect; Rifampicin, an antibiotic.</p><p>&sect; Folinic acid.</p><p>&sect; Contraceptive medicines.</p><p><strong>TRIMOL with food and drink&nbsp;&nbsp; </strong></p><p>Your child should take <strong>TRIMOL </strong>with some food or drink. This will stop them feeling sick (nausea) or having diarrhoea. Although it is better to take it with food, they can still take it on an empty stomach.</p><p>Make sure your child drink plenty of fluid such as water while they are taking <strong>TRIMOL</strong>.&nbsp;</p><p><strong>Important information about some of the ingredients of TRIMOL </strong></p><p><strong>TRIMOL</strong> Paediatric Suspension contains:</p><p>&sect; Sorbitol, saccharin&ndash; If you have been told by your child&rsquo;s doctor that your child cannot tolerate or digest some sugars (have intolerance to some sugars), contact your child&rsquo;s doctor before taking this medicinal product.</p><p>&sect; Methyl paraben and propyl paraben, which may cause allergic reactions (possibly delayed).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always ensure your child takes <strong>TRIMOL</strong> exactly as their doctor or pharmacist has told you. Check with their doctor or pharmacist if you are not sure.</p><p><strong>Standard Dose&nbsp; </strong></p><p>Standard dosage recommendations for acute infections</p><p><em>Children aged 12 years and under (infants (&gt;6 weeks to &lt;2 years old) and children (&gt;2 to &lt;12 years old) </em>:</p><p>The schedules for children are according to the child&rsquo;s age and body weight provided in the table below:</p><table border="1" cellspacing="0" cellpadding="0" style="width:360px"><tbody><tr><td style="vertical-align:top"><p><strong>Standard dosage </strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Age</strong></p></td><td style="vertical-align:top"><p><strong>Paediatric suspension</strong></p></td></tr><tr><td style="vertical-align:top"><p>6 to 12 years</p></td><td style="vertical-align:top"><p>10 mL (two teaspoonfuls) in a morning and 10 mL (two teaspoonfuls) in an evening</p></td></tr><tr><td style="vertical-align:top"><p>6 months to 5 years</p></td><td style="vertical-align:top"><p>5mL (one teaspoonful) in a morning and 5mL (one teaspoonful) in an evening</p></td></tr><tr><td style="vertical-align:top"><p>6 weeks to 5 months</p></td><td style="vertical-align:top"><p>2.5mL (<sup>1</sup>/<sub>2 </sub>teaspoonful) in a morning and 2.5mL (<sup>1</sup>/<sub>2</sub> teaspoonful) in an evening</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>The dosage for children is equivalent to approximately 6mg trimethoprim and 30mg sulphamethoxazole per kg body weight per day</p></td></tr></tbody></table><p>&nbsp;</p><p>&sect; <strong>TRIMOL</strong> should be taken for at least five days&nbsp;&nbsp;</p><p>&sect; Make sure that your child finishes the course of <strong>TRIMOL</strong> which their doctor has prescribed.</p><p><strong>&nbsp;Special dose&nbsp; </strong></p><p>The dose of <strong>TRIMOL</strong> and how long your child needs to take it depends on the infection they have and how bad it is. Your child&rsquo;s doctor may prescribe you a different dose or length of course of <strong>TRIMOL</strong> to:</p><p>&sect; Treat urinary tract (water) infections.&nbsp;</p><p>&sect; Treat and prevent lung infections caused by the bacteria <em>pneumocystis jirovecii </em>(PJP)<em>. </em></p><p>&sect; Treat infections caused by the bacteria toxoplasma (toxoplasmosis) or nocardia (nocardiosis) or brucella (brucellosis).</p><p><strong>If your child has kidney problems their doctor may: </strong></p><p>&sect; Prescribe a lower dose of <strong>TRIMOL</strong>.</p><p>&sect; Take blood to test whether the medicine is working properly.</p><p><strong>If your child takes TRIMOL</strong> <strong>for a long time their doctor may </strong></p><p>&sect; Take blood to test whether the medicine is working properly.</p><p>&sect; Prescribe folic acid (a vitamin) for your child to take at the same time as <strong>TRIMOL</strong>.</p><p><strong>If your child takes more TRIMOL</strong> <strong>than they should </strong></p><p>If your child takes more <strong>TRIMOL</strong> than they should, talk to their doctor or go to a hospital straight away. Take the medicine pack with you.&nbsp;</p><p>If your child has taken too much <strong>TRIMOL</strong> they may:</p><p>&sect; Feel or be sick.</p><p>&sect; Feel dizzy or confused. &nbsp;</p><p><strong>If you forget to give your child TRIMOL</strong></p><p>&sect; If a dose is forgotten, your child should take it as soon as possible.</p><p>&sect; Do not give your child a double dose to make up for the forgotten dose.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, <strong>TRIMOL</strong> can cause side effects, although not everybody gets them.</p><p>Your child may experience the following side effects with this medicine.&nbsp;</p><p>Stop giving your child <strong>TRIMOL</strong> and tell your child&rsquo;s doctor immediately if your child has an allergic reaction. Chances of an allergic reaction is very rare (fewer than 1 in 10,000 people are affected), signs of an allergic reaction include:</p><p>&sect; Difficulty in breathing.</p><p>&sect; Fainting.</p><p>&sect; Swelling of face.</p><p>&sect; Swelling of mouth, tongue or throat which may be red and painful and/or cause difficulty in swallowing.</p><p>&sect; Chest pain.</p><p>&sect; Red patches on the skin.</p><p>Your child may also experience the following side effects with this medicine:</p><p><strong>Very Common (more than 1 in 10 people)</strong></p><p>&sect; High levels of potassium in your blood, which can cause abnormal heart beats (palpitations).</p><p><strong>Common (less than 1 in 10 people)</strong></p><p>&sect; A fungal infection called thrush or candidiasis which can affect the mouth or vagina.</p><p>&sect; Headache.</p><p>&sect; Feeling sick (nausea).</p><p>&sect; Diarrhoea.</p><p>&sect; Skin rashes.</p><p><strong>Uncommon (less than 1 in 100)</strong></p><p>&sect; Being sick (vomiting).</p><p><strong>Very Rare (less than 1 in 10,000 people)</strong></p><p>&sect; Fever (high temperature) or frequent infections.</p><p>&sect; Sudden wheeziness or difficulty breathing.</p><p>&sect; Mouth ulcers, cold sores and ulcers or soreness of the tongue.</p><p>&sect; Skin lumps or hives (raised, red or white, itchy patches of skin).</p><p>&sect; Blisters on the skin or inside the mouth, nose, vagina or bottom.</p><p>&sect; Potentially life-threatening skin rashes (Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported (see Warnings and precautions).</p><p>&sect; Inflammation of the eye which causes pain and redness.</p><p>&sect; The appearance of a rash or sunburn when your child has been outside (even on a cloudy day).</p><p>&sect; Low levels of sodium in the blood.</p><p>&sect; Changes in blood tests (low blood cell counts).</p><p>&sect; Feeling weak, tired or listless, pale skin (anaemia).</p><p>&sect; Heart problems.</p><p>&sect; Jaundice (the skin and the whites of the eyes turn yellow). This can occur at the same time as unexpected bleeding or bruising.</p><p>&sect; Pains in the stomach, which can occur with blood in the faeces (poo).</p><p>&sect; Pains in the chest, muscles or joints and muscle weakness.</p><p>&sect; Arthritis.</p><p>&sect; Problems with the urine. Difficulty passing urine. Passing more or less urine than usual. Blood or cloudiness in the urine.</p><p>&sect; Kidney problems.</p><p>&sect; Sudden headache or stiffness of the neck, accompanied by fever (high temperature).</p><p>&sect; Problems controlling movements.</p><p>&sect; Fits (convulsions or seizures).</p><p>&sect; Feeling unsteady or giddy.</p><p>&sect; Ringing or other unusual sounds in the ears.</p><p>&sect; Tingling or numbness in the hands and feet.</p><p>&sect; Seeing strange or unusual sights (hallucinations).</p><p>&sect; Depression.</p><p>&sect; Muscle pain and/or muscle weakness in HIV patients.</p><p>&sect; Cough.</p><p>&sect; Loss of appetite.</p><p>&sect; Hypoglycaemia (an abnormally low level of glucose in the blood).</p><p>&sect; Pseudomembranous colitis (Acute inflammation of the small and large intestinal mucosa with formation of pseudomembranous plaques over superficial ulceration.).</p><p>&sect; Pancreatitis (Acute inflammation of the pancreas).</p><p>&sect; Vertigo (An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space).</p><p>&sect; Hepatic necrosis (which may be fatal) (breakdown/death of liver tissue).</p><p><strong>Unknown frequency (cannot be estimated from the available data)</strong></p><p>&sect; Psychotic disorder (a mental state in which you may lose touch with reality)</p><p><strong>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your child&rsquo;s doctor or pharmacist.</strong></p><p><strong><u>&nbsp;</u></strong></p><p><strong><u>Reporting of side effects</u></strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><p><strong>The National Pharmacovigilance and Drug Safety Center (NPC)</strong></p><p><strong>Fax:</strong> +966-11-205-7662</p><p><strong>Call NPC at</strong> +966-11-2038222, <strong>Exts:</strong> 2317-2356-2340</p><p><strong>Reporting Hotline:</strong> 19999</p><p><strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p><strong>Website:</strong> www.sfda.gov.sa/npc</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States: </strong>Please contact the relevant competent authority.</p><p>&nbsp;</p><p>By reporting side effects, you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp; Do not give <strong>TRIMOL </strong>after the expiry date which is stated on the carton and on the inner label.</p><p>-&nbsp; Store below 30&deg;C. After opening, use within one month.</p><p>-&nbsp; Do not give <strong>TRIMOL </strong>if you notice any visible sign of deterioration.</p><p>-&nbsp; Medicines should<em> </em>not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p><p>&nbsp;</p><p style="margin-left:9.0pt; text-align:justify; text-indent:-4.5pt"><!--[if !supportLists]--></p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Each teaspoonful (5mL) of the suspension contains:</p><p>Active ingredients:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Trimethoprim&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp;&nbsp;&nbsp;40mg</p><p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Sulphamethoxazole&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 200mg</p><p>The other ingredients: Glycerol, saccharin sodium, citric acid monohydrate, sucrose, tween 80, carboxymethyl cellulose sodium, aluminium magnesium silicate, methyl paraben, propyl paraben, propylene glycol, sorbitol, polyvinyl pyrrolidone, colloidal silicon dioxide, flavours (apricot and banana), raspberry red colour, FD&amp;C Red 40, and purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                TRIMOL paediatric suspension is available in packs containing one bottle (50mL or 100mL) each.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries &quot; Julphar&quot;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                08/12/2019



            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي معلق <strong>ترايمول </strong>للأطفال على مادتين دوائيتين مختلفتين تعرف إحداهما باسم سلفاميثوكسازول والأخرى باسم تراي ميثوبريم ويستخدم لعلاج حالات العدوى الناجمة عن البكتيريا. كما يطلق على هذين الدواءين معاً باسم كوترايموكسازول. كما هو عليه الحال مع جميع المضادات الحيوية، يعمل <strong>ترايمول </strong>فقط ضد بعض أنواع البكتيريا. مما يعني أنه ملائم فقط لعلاج بعض أنواع العدوى.</p><p dir="RTL"><strong>يمكن استعمال ترايمول للعلاج أو للوقاية من: </strong></p><p dir="RTL">●&nbsp;&nbsp;&nbsp; حالات العدوى التي تصيب الرئة (الالتهاب الرئوي) والتي تسببها بكتيريا نيموسيستس جروفيسي (تعرف سابقاً باسم نيموسيستس كاريني) (كما يطلق بعض الأشخاص على<br />&nbsp;&nbsp;&nbsp; هذه الحالة باسم التهاب المكورات الرئوية)</p><p dir="RTL"><strong>يمكن استعمال ترايمول لعلاج الحالات التالية:</strong></p><p dir="RTL">●&nbsp;&nbsp;&nbsp; العدوى التي تصيب المثانة أو المسالك البولية</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; عدوى الجهاز التنفسي على سبيل المثال التهاب الشعب الهوائية</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; العدوى التي تصيب الأذن على سبيل المثال التهاب الأذن الوسطى</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; عدوى تعرف باسم النوكارديا، والتي قد تصيب الرئتين، الجلد والدماغ.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; العدوى التي تسببها بكتيريا التوكسوبلازما (داء التوكسوبلازما أو المقوسات).</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; عدوى تعرف باسم داء البروسيلات، في حال كان تلقي العلاجات الأخرى غير فعالة ويتم إعطائه على هيئة علاج مشترك مع<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية الأخرى بحيث يتوافق مع الإرشادات العلاجية الوطنية.</p><p dir="RTL">يجب أن تؤخذ الإرشادات الطبية&nbsp; بعين الاعتبار حول الاستعمال الملائم للمضادات الحيوية.</p><p dir="RTL">يتم إعطاء معلق <strong>ترايمول </strong>للأطفال بعمر 12 سنة وأقل ((الأطفال الرضع بعمر &gt;6 أسابيع إلى &lt;2 سنة) والأطفال (بعمر يتراوح من &gt;2 إلى &lt;12 سنة)).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عدم إعطاء ترايمول لطفلك في الحالات التالية:</strong></p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إذا كان يعاني من الحساسية تجاه سلفاميثوكسازول، تراي ميثوبريم أو كوترايموكسازول أو أياً من المكونات الأخرى في هذا الدواء (المذكورة&nbsp; في البند رقم 6)</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إذا كان يعاني من الحساسية تجاه الأدوية من مجموعة السلفوناميد، على سبيل المثال أدوية السلفونيل يوريا (بما في ذلك الجليكلازيد والجلايبنكلاميد) أو مدرات البول من<br />&nbsp;&nbsp;&nbsp;&nbsp; مجموعة الثيازيد (على سبيل المثال بندروفلوميثيازيد &ndash; قرص مدر للبول)</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إذا كان يعاني من اضطرابات شديدة في الكبد أو الكلى</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إذا عانى مسبقاً من اضطرابات في الدم مما تؤدي إلى حدوث كدمات أو نزيف (قلة الصفيحات)</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إذا كان قد أخبرك طبيبك المعالج بأن طفلك يعاني من حالة مرضية تعرف باسم البورفيريا، التي من الممكن أن تؤثرعلى</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجلد أو الجهاز العصبي.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; يجب عدم إعطاء <strong>ترايمول </strong>للأطفال الرضع بعمر 6 أسابيع أو أقل</p><p dir="RTL">يرجى منك استشارة الطبيب المعالج لطفلك أو الصيدلي الذي تتعامل معه قبل إعطاء <strong>ترايمول</strong>، إذا كان لديك أدنى شك بأن أياً مما ذكر أعلاه ينطبق على طفلك.</p><p dir="RTL"><strong>التحذيرات والاحتياطات</strong></p><p dir="RTL">سجل حدوث طفح جلدي ومن المحتمل أن يكون مهدد للحياة (متلازمة ستيفن-جونسون، انحلال البشرة السمي التنخري) مع استعمال كوترايموكسازول الذي يظهر في البداية على هيئة بقع حمراء محددة أو بقع دائرية وغالباً ما يكون مصحوباً بتقرحات مركزية على الجسم. علامات إضافية التي يجب أن تؤخذ بعين الاعتبار تتضمن على تقرحات في الفم، الحلق، الأنف، الأعضاء التناسلية والتهاب الملتحمة (تورم واحمرار العينين). إن هذا النوع من الطفح الجلدي الذي قد يهدد الحياة غالباً ما يكون مصحوباً بأعراض تشابه أعراض الإنفلونزا. وقد يتطور إلى تقرحات منتشرة على الجسم أو تقشر في الجلد. إن معدل خطر حدوث التفاعلات الجلدية الخطيرة تكون أعلى خلال الأسابيع الأولى من العلاج. إذا أصيب طفلك بمتلازمة ستيفن -جونسون أو انحلال البشرة السمي التنخري أثناء فترة تناول <strong>ترايمول</strong>، فيجب عدم إعطاء الطفل <strong>ترايمول</strong> مرة أخرى في أي وقت آخر. في حال تعرض طفلك للإصابة بأي طفح جلدي أو أياً من هذه الأعراض الجلدية، فيجب عليك التوقف عن إعطاء <strong>ترايمول</strong>، وقم بطلب المشورة الطبية العاجلة من الطبيب المعالج، وأخبره بأن طفلك يتناول هذا الدواء.</p><p dir="RTL"><strong>يرجى منك إخبار الطبيب المعالج لطفلك أو الصيدلي الذي تتعامل معه قبل إعطاء ترايمول في الحالات التالية:</strong></p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إذا كان يعاني من حساسية شديدة أو داء الربو القصبي.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إذا أخبرك الطبيب المعالج بأن طفلك معرض لخطر الإصابة باضطراب نادرة في الدم يعرف باسم البورفيريا.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إذا كان مستويات حمض الفوليك (إحدى أنواع الفيتامينات) في جسم الطفل غير كافية لتلبية احتياجات الجسم - الأمر الذي يؤدي إلى شحوب لون الجلد والشعور بالتعب،<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف وضيق في التنفس. تعرف هذه الحالة باسم فقر الدم.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إذا كان يعاني من اضطراب يعرف باسم&nbsp;عوزِ سداسي فوسفات الجلوكوز النازع للهيدروجين، الذي قد يسبب في حدوث يرقان أو انحلال خلايا الدم الحمراء التلقائي.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إذا كان يعاني من اضطراب في عملية الأيض تعرف باسم الفينيل كيتون يوريا ولا يخضع لأي حمية غذائية خاصة للمساعدة في تحسين حالته الصحية.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إذا كان الطفل يعاني من نقص في الوزن أو سوء التغذية.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إذا أخبرك الطبيب المعالج&nbsp; لطفلك بأنه يعاني من ارتفاع شديد في مستويات البوتاسيوم في الدم أو في حال كان طفلك يتلقى الأدوية التي تسبب في ارتفاع مستويات البوتاسيوم<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في الدم، على سبيل المثال أقراص مدرات البول (التي تساعد على زيادة إدرار البول)، الستيرويدات (على سبيل المثال بريدنيزولون) وديجوكسين. من الممكن أن يؤدي<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع مستويات البوتاسيوم في الدم بصورة شديدة إلى حدوث اضطرابات في نظم ضربات القلب (خفقان)، غثيان، دوخة أو صداع.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إذا أخبرك الطبيب المعالج&nbsp; لطفلك بأنه يعاني من انخفاض مستويات الصوديوم في الدم بصورة غير طبيعية</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إذا أخبرك الطبيب المعالج&nbsp; لطفلك بأنه يعاني من أية اضطرابات خطيرة في الدم والأنسجة المكونة للدم (اضطرابات الدم). على سبيل المثال انخفاض تعداد خلايا الدم.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إذا كان يعاني من اضطراب في الكلى</p><p dir="RTL"><strong>تناول الأدوية الأخرى بالتزامن مع ترايمول </strong></p><p dir="RTL">يرجى منك إخبار الطبيب المعالج لطفلك أو الصيدلي الذي تتعامل معه إذا كان طفلك يتناول، تناول مؤخراً أو قد يتناول أية أدوية أخرى، وذلك لأن<strong> ترايمول</strong> قد يؤثر على آلية عمل بعض الأدوية، كما أن بعض الأدوية الأخرى قد تؤثر على آلية عمل <strong>ترايمول</strong>.</p><p dir="RTL"><strong>بصفة خاصة، يرجى منك إخبار الطبيب المعالج لطفلك أو الصيدلي الذي تتعامل معه إذا كان طفلك يتناول أياً من الأدوية التالية:</strong></p><p dir="RTL">●&nbsp;&nbsp;&nbsp; أقراص مدرات البول، التي تساعد على زيادة إدرار البول</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; بيريميثامين، يُستخدم للعلاج وللوقاية من الملاريا، كما يُستخدم لعلاج الإسهال.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; سيكلوسبورين، يُستخدم بعد عمليات زراعة الأعضاء</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; الأدوية التي تُستخدم لترقيق الدم على سبيل المثال الوارفارين.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; فينيتوين، يستخدم لعلاج نوبات الصرع (التشنجات).</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; الأدوية التي تُستخدم لعلاج داء السكري، على سبيل المثال جلايبنكلاميد، جليبيزيد أو تولبيوتاميد (الأدوية من مجموعة السلفونيل يوريا) و ريباجلينيد</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; الأدوية التي تُستخدم لعلاج المشاكل المتعلقة بنظم ضربات القلب على سبيل المثال الديجوكسين أو البروكاييناميد.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; أمانتادين، يُستخدم لعلاج مرض باركنسون، داء تصلب الأنسجة التعددي، الإنفلونزا أو الهربس النطاقي.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; الأدوية التي تستخدم لعلاج فيروس إتش آي في (فيروس نقص المناعة البشرية المكتسبة)، وتعرف باسم زيدوفودين أو لاميفودين.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; الأدوية التي تؤدي إلى ارتفاع مستويات البوتاسيوم في الدم، على سبيل المثال أقراص مدرات البول (التي تساعد على زيادة إدرار البول على سبيل المثال سبيرونولاكتون)، الستيرويدات (على سبيل المثال بريدنيزولون) وديجوكسين.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; أزاثيوبرين، يمكن استخدامه للمرضى بعد إجراء عملية زراعة الأعضاء أو لعلاج اضطرابات الجهاز المناعي أو داء الأمعاء الالتهابي</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; ميثوتريكسات، وهو دواء يُستخدم لعلاج حالات معينة من السرطان أو اضطرابات معينة تؤثر على الجهاز المناعي.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; ريفامبيسين، مضاد حيوي.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; حمض الفولينيك.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; أدوية منع الحمل</p><p dir="RTL"><strong>تناول ترايمول مع الطعام والشراب</strong></p><p dir="RTL">يجب على طفلك أن يتناول<strong> ترايمول </strong>مع بعض الطعام أو الشراب. سوف يساعد ذلك على عدم شعوره بالإعياء (غثيان) أو عدم إصابته بإلاسهال. بالرغم أنه من الأفضل تناول هذا الدواء مع الطعام، إلا أنه يمكن تناوله على معدة فارغة.</p><p dir="RTL">&nbsp;يجب التأكد من أن طفلك يتناول كميات وافرة من السوائل على سبيل المثال الماء أثناء فترة تناول <strong>ترايمول</strong>.</p><p dir="RTL"><strong>معلومات هامة حول بعض مكونات ترايمول</strong></p><p dir="RTL">يحتوي معلق<strong> ترايمول </strong>للأطفال على:</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; السوربيتول (ذو تأثير ملين لطيف)، سكارين والسكروز&ndash; إذا كان قد أخبرك الطبيب المعالج لطفلك بأن طفلك يعاني من مشكلة تتمثل في عدم القدرة على تحمل أو هضم بعض<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أنواع السكر، فيرجى منك استشارة الطبيب المعالج لطفلك قبل إعطائه <strong>ترايمول</strong>.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; ميثيل البارابين وبروبيل البارابين، قد تسبب في حدوث تفاعلات تحسسية (من المحتمل أن تظهر بصورة متأخرة).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب عليك إعطاء <strong>ترايمول </strong>لطفلك<strong> </strong>دائماً بدقة وفقاً لتعليمات الطبيب المعالج لطفلك أو الصيدلي الذي تتعامل معه. يرجى منك استشارة الطبيب المعالج لطفلك أو الصيدلي الذي تتعامل معه إذا لم تكن متأكداً من كيفية إعطاء هذا الدواء.</p><p dir="RTL"><strong><u>الجرعة القياسية</u></strong></p><p dir="RTL"><strong>مقدار الجرعة القياسية الموصى بها لعلاج حالات العدوى الحادة </strong></p><p dir="RTL">الأطفال بعمر 12 <strong>سنة</strong> وأقل ((الأطفال الرضع بعمر &gt;6 أسابيع إلى &lt;2 سنة) والأطفال (بعمر يتراوح من &gt;2 إلى &lt;12 سنة)):</p><p dir="RTL">تم تحديد جدول الجرعات المخصص للأطفال أدناه وفقاً لعمر الطفل ووزن الجسم:</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:330px"><tbody><tr><td colspan="2" style="vertical-align:top"><p dir="RTL"><strong>الجرعة القياسية</strong></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL"><strong>العمر</strong></p></td><td style="vertical-align:top"><p dir="RTL"><strong>معلق ترايمول للأطفال</strong></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL"><strong>6 إلى 12 سنة</strong></p></td><td style="vertical-align:top"><p dir="RTL">10 ملليلتر (2 ملعقة صغيرة) صباحاً و 10 ملليلتر (2 ملعقة صغيرة) مساءً</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL"><strong>6 شهور إلى 5 سنوات</strong></p></td><td style="vertical-align:top"><p dir="RTL">5 ملليلتر (ملعقة صغيرة واحدة) صباحاً و 5 ملليلتر (ملعقة صغيرة واحدة) مساءً</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL"><strong>6 أسابيع إلى 5 شهور</strong></p></td><td style="vertical-align:top"><p dir="RTL">2,5 ملليلتر (<sub>2</sub>/<sup>1</sup> ملعقة صغيرة) صباحاً&nbsp; و 2,5 ملليلتر (<sub>2</sub>/<sup>1</sup> ملعقة صغيرة) مساءً</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL"><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p dir="RTL">يبلغ مقدار الجرعة للأطفال ما يقارب 6 ملغم من تراي ميثوبريم و 30 ملغم من سلفا ميثوكسازول لكل كيلوغرام من الجسم في اليوم.</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">●&nbsp;&nbsp; يجب تناول<strong> ترايمول </strong>لمدة خمسة أيام على الأقل.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; يجب التأكد من أن طفلك قد أنهى الدورة العلاجية من <strong>ترايمول </strong>كاملةً كما هو موصى به من قبل الطبيب المعالج.</p><p dir="RTL"><strong><u>الجرعة المخصصة </u></strong></p><p dir="RTL">إن جرعة<strong> ترايمول </strong>والفترة العلاجية اللازمة لطفلك تعتمد على نوع العدوى التي يعاني منها ومدى شدتها.</p><p dir="RTL">قد يصف الطبيب المعالج&nbsp; لطفلك جرعة مختلفة أو دورة علاجية أطول من<strong> ترايمول</strong> في الحالات التالية:</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; لعلاج عدوى المسالك البولية</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; للعلاج وللوقاية من عدوى الرئة التي تسببها نيموسيستس جروفيسي</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; علاج العدوى التي تسببها بكتيريا التوكسوبلازما (داء التوكسوبلازما أو المقوسات) أو النوكارديا (داء النوركارديات) أو بروسيلا (داء البروسيلات).</p><p dir="RTL"><strong>إذا كان طفلك يعاني من اضطرابات في الكلى، فقد يقوم الطبيب المعالج باتخاذ الإجراءات التالية:</strong></p><p dir="RTL">●&nbsp;&nbsp;&nbsp; وصف مقدار جرعة أقل من <strong>ترايمول</strong></p><p dir="RTL">●&nbsp;&nbsp;&nbsp; أخذ عينة من الدم لفحصها للتأكد ما إذا كان الدواء يعمل بالكفاءة المطلوبة.</p><p dir="RTL"><strong>إذا تناول طفلك</strong> <strong>ترايمول لمدة طويلة، فقد يقوم الطبيب المعالج باتخاذ الإجراءات التالية:</strong></p><p dir="RTL">●&nbsp;&nbsp;&nbsp; أخذ عينة من الدم لفحصها للتأكد ما إذا كان الدواء يعمل بالكفاءة المطلوبة.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; يصف لطفلك حمض الفوليك (إحدى أنواع الفيتامينات) على أن يتم تناوله بالتزامن مع <strong>ترايمول</strong>.</p><p dir="RTL"><strong>إذا قمت بإعطاء ترايمول لطفلك بجرعة أكبر مما يجب </strong></p><p dir="RTL">يرجى منك التحدث إلى الطبيب المعالج أو التوجه إلى أقرب مستشفى على الفور، إذا قمت بإعطاء <strong>ترايمول</strong> لطفلك بجرعة أكبر مما يجب عليه تناولها، وقم بأخذ عبوة الدواء معك.</p><p dir="RTL">إذا تناول طفلك <strong>ترايمول </strong>بجرعة مفرطة فقد يشعر بما يلي:</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; الشعور بالإعياء أو التوعك</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; الشعور بالدوخة أو الارتباك.</p><p dir="RTL"><strong>إذا سهوت عن إعطاء ترايمول لطفلك </strong></p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إذا سهوت عن إعطاء إحدى جرعات <strong>ترايمول</strong> لطفلك فيجب عليك إعطائه هذه الجرعة في أقرب وقت ممكن.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; يجب عليك عدم إعطاء طفلك جرعة مضاعفة للتعويض عن الجرعة التي قد سهوت عنها.</p><p dir="RTL"><strong>يرجى منك استشارة الطبيب المعالج لطفلك أو الصيدلي الذي تتعامل معه، إذا كانت لديك أية أسئلة إضافية حول استعمال هذا الدواء.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو عليه الحال مع جميع الأدوية، قد يؤدي <strong>ترايمول </strong>إلى حدوث تأثيرات جانبية، بالرغم من ذلك فهي لا تحدث لكل شخص.</p><p dir="RTL">قد يتعرض طفلك للتأثيرات الجانبية التالية أثناء فترة تناول هذا الدواء.</p><p dir="RTL">يجب التوقف عن إعطاء <strong>ترايمول </strong>ويرجى منك إخبار الطبيب المعالج لطفلك على الفور إذا عانى طفلك من أية تفاعلات تحسسية. إن فرص حدوث التفاعل التحسسي تعد نادرة جداً (تصيب أقل من شخص واحد من كل 10000 شخص)، وتتضمن علامات التفاعل التحسسي على ما يلي:</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; صعوبة في التنفس</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إغماء</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; تورم الوجه</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; تورم الفم، اللسان، أو الحلق الذي قد يصبح ذو لون أحمر مع شعور بألم و/أو صعوبة في البلع</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; ألم في الصدر</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; بقع حمراء على الجلد.</p><p dir="RTL"><strong>كما قد يعاني طفلك من التأثيرات الجانبية التالية أثناء فترة استعمال هذا الدواء:</strong></p><p dir="RTL"><strong>شائعة جداً (تصيب أكثر من شخص واحد من كل 10 أشخاص)</strong></p><p dir="RTL">●&nbsp;&nbsp;&nbsp; مستويات عالية من البوتاسيوم في الدم مما قد يسبب اضطراب في نظم ضربات القلب (خفقان).</p><p dir="RTL"><strong>شائعة (تصيب أقل من شخص واحد من كل 10أشخاص)</strong></p><p dir="RTL">●&nbsp;&nbsp;&nbsp; عدوى ناجمة عن الفطريات تعرف باسم القلاع أو الكانديدا التي يمكن أن تصيب الفم أو المهبل</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; صداع</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; الشعور بالإعياء (غثيان)</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; إسهال</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; طفح جلدي.</p><p dir="RTL"><strong>غير شائعة (تصيب أقل من شخص واحد من كل 100 شخص)</strong></p><p dir="RTL">●&nbsp;&nbsp;&nbsp; الشعور بالتوعك<strong> </strong>(تقيؤ).</p><p dir="RTL"><strong>نادرة جداً (تصيب أقل من شخص واحد من كل 10000 شخص)</strong></p><p dir="RTL">●&nbsp;&nbsp;&nbsp; حمى (ارتفاع درجة الحرارة) أو الإصابة بعدوى متكررة</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; حدوث أزيز بصورة مفاجئة أو صعوبة في التنفس</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; تقرحات فموية، تقرحات باردة وتقرحات اللسان.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; تكتلات جلدية أو طفح جلدي على شكل خلايا النحل (بقع حمراء أو بيضاء مرتفعة عن سطح الجلد مصحوبة بحكة)</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; ظهور بثور على الجلد أو داخل الفم، الأنف، المهبل أو المؤخرة</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; سجلت تقارير حول حدوث حالات من الطفح الجلدي والتي غالباً ما تكون مهددة للحياة (متلازمة ستيفن-جونسون، انحلال<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البشرة السمي التنخري) (انظر قسم التحذيرات والاحتياطات).</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; التهاب العين الذي يسبب ألم واحمرار</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; ظهور طفح جلدي أو حروق جلدية الناجمة عن أشعة الشمس عند تعرض الطفل لها (حتى وإن كان الجو غائماً)</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; انخفاض مستويات الصوديوم في الدم</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; تغيرات في نتائج فحوصات الدم (انخفاض تعداد خلايا الدم)</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; الشعور بالضعف، تعب أو فتور، شحوب لون الجلد (فقر الدم)</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; اضطرابات في القلب</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; يرقان (اصفرار الجلد وبياض العينين). قد يحدث ذلك بالتزامن مع حدوث كدمات أو نزيف غير متوقع.</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; ألم في المعدة، الذي قد يكون مصحوباً ببراز دموي</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; ألم في الصدر، العضلات أو المفاصل وضعف في العضلات</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; التهاب المفاصل</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; اضطرابات في التبول. صعوبة في التبول. إدرار البول بصورة أكبر أو أقل من المعتاد. تغير لون البول ليصبح معكر أو يكون مصحوباً بدم</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; اضطرابات في الكلى</p><p dir="RTL">●&nbsp;&nbsp;&nbsp;&nbsp; صداع مفاجئ أو تصلب في الرقبة، مصحوباً بحمى (ارتفاع الحرارة).</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; مشاكل في تناسق الحركة</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; تشنجات (اختلاجات أو نوبات صرع)</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; الشعور بالدوخة أو عدم التوازن</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; رنين في الأذن أو سماع أصوات أخرى غير اعتيادية في الأذنين</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; الشعور بالتنميل أو بالتخدر في اليدين والقدمين</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; رؤية أشياء غريبة أو غير اعتيادية (هلوسة)</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; اكتئاب</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; ألم في العضلات و/أو ضعف في العضلات لدى المرضى الذي يعانون من فيروس نقص المناعة البشرية المكتسبة</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; سعال</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; فقدان الشهية</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; انخفاض مستوى السكر في الدم (انخفاض مستوى الجلوكوز في الدم بصورة غير طبيعية).</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; التهاب القولون الغشائي الكاذب (التهاب حاد في الغشاء المخاطي في الأمعاء الغليظة والدقيقة مصحوباً بتكون لويحات غشائية كاذبة على سطح التقرح).</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; التهاب البنكرياس (التهاب حاد في البنكرياس).</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; الدوار (وهم بوجود حركة ، إما من الذات أو الأشياء المحيطة به).</p><p dir="RTL">●&nbsp;&nbsp;&nbsp; النخر الكبدي (الذي قد يسبب الوفاة) (تلف أنسجة الكبد).</p><p dir="RTL"><strong>الغير معروفة (لايمكن تحديد معدل تكرار حدوثها من البيانات المتاحة)</strong></p><p dir="RTL">●&nbsp;&nbsp;&nbsp; الاضطرابات العقلية (حالات الصحة&nbsp;العقلية التي تفصل الفرد عن الواقع)</p><p dir="RTL"><strong>يرجى منك إخبار الطبيب المعالج لطفلك أو الصيدلي الذي تتعامل معه في حال زيادة حدة أياً من&nbsp; التأثيرات الجانبية أو ملاحظة حدوث أية تأثيرات جانبية يحتمل حدوثها ولم يتم ذكرها في هذه النشرة.</strong></p><p dir="RTL"><strong><u>&nbsp;</u></strong></p><p dir="RTL"><strong><u>للإبلاغ عن حدوث أية تأثيرات جانبية:</u></strong></p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه، في حال حدوث أياً من التأثيرات الجانبية، بما في ذلك أية تأثيرات جانبية يحتمل حدوثها ولم يتم ذكرها في هذه النشرة. يمكنك الإبلاغ عن التأثيرات الجانبية مباشرة عن طريق:</p><p dir="RTL">●<strong>&nbsp;&nbsp;&nbsp; المملكة العربية السعودية:</strong></p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المركز الوطني للتيقظ والسلامة الدوائية</strong></p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رقم الفاكس:&nbsp; </strong>&nbsp;7662-205-11-966+</p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يرجى الاتصال بالمركز الوطني للتيقظ والسلامة الدوائية على:</strong> 2038222-11-966+</p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وصلة هاتف:</strong>2340-2356-2317</p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الخط الساخن: </strong>19999</p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني:&nbsp; </strong>npc.drug@sfda.gov.sa</p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: </strong>www.sfda.gov.sa/npc</p><p dir="RTL">●<strong>&nbsp;&nbsp;&nbsp; دول الخليج العربي الأخرى:</strong> الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إن تسجيل التأثيرات الجانبية يساعد في توفير مزيد من المعلومات حول سلامة هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;-&nbsp; &nbsp; يجب عدم إعطاء <strong>ترايمول</strong> بعد تاريخ انتهاء الصلاحية المذكور على العبوة والملصق الداخلي للزجاجة.</p><p dir="RTL">&ndash;&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة أقل من &ordm;30م. بعد الفتح، يستخدم المعلق خلال شهر واحد.</p><p dir="RTL">&ndash;&nbsp;&nbsp;&nbsp; يجب عدم إعطاء <strong>ترايمول</strong> إذا لاحظت وجود علامات تلف واضحة.</p><p dir="RTL">&ndash;&nbsp;&nbsp;&nbsp; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تحتوي كل ملعقة صغيرة (5 ملليلتر) من المعلق على:</p><p dir="RTL">المواد الفعالة:&nbsp; تراي ميثوبريم&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 40 ملغم</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سلفا ميثوكسازول&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 200 ملغم</p><p dir="RTL">المواد الأخرى:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جليسيرول، سكارين الصوديوم، حمض الستريك أحادي الهيدرات، سكروز، توين 80، كربوكسي مثيل سليلوز صوديوم، سيليكات الألومنيوم المغنيسيوم،<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ميثيل البارابين، بروبيل البارابين، بروبيلين جلايكول، سوربيتول، بولي فينيل بيروليدون، ثنائي أكسيد السليكون الغروي، نكهات (المشمش والموز)، لون<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التوت الأحمر، إف دي وسي أحمر 40، وماء منقى.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يتوفر معلق <strong>ترايمول </strong>للأطفال<strong> </strong>في عبوات تحتوي كلاً منها على زجاجة واحدة (سعة 50 ملليلتر أو 100 ملليلتر).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&quot;الخليج للصناعات الدوائية&quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            08/12/2019م

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Trimol Suspension
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1.		Trimethoprim (micronized)	40.00
2.		Sulphamethoxazole (Micronized)	200.00
		
	Inactive Ingredients:	
1.		Glycerol 	350.00
2.		Saccharin sodium	5.00
3.		Citric acid monohydrate	3.00
4.		Sucrose	2200.00
5.		Tween 80	20.00
6.		Apricot flavour	5.00
7.		Banana flavour	5.00
8.		Raspberry red colour	0.035
9.		FD&C red 40	0.025
10.		CMC sodium	22.50
11.		Aluminium magnesium silicate (veegum HV)	20.00
12.		Methyl paraben	5.00
13.		Propyl paraben	1.50
14.		Propylene glycol	400.00
15.		Sorbitol 70%	375.00
16.		Polyvinyl pyrrolidone (PVP-K-30)	5.00
17.		Colloidal silicon dioxide (Aerosil 200)	12.50
18.		Purified water.	q.s. to 5mL


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oral Suspension
Description: Light pink suspension, fruity odour with palatable taste.   


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><strong>Trimol</strong> Paediatric Suspension is indicated in children aged 12 years and under (infants (&gt;6 weeks to &lt;2 years old) and children (&gt;2 to &lt;12 years old) for the treatment of the following infections when owing to sensitive organisms (see section 5.1) :</p><p style="margin-left:18.0pt; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]-->&sect; <!--[endif]--><em>Urinary tract infections: </em>For simple urinary tract infections, trimethoprim alone or another single antimicrobial agent is the preferred treatment. Since trimethoprim is also as efficacious as co-Trimoxazole for the prophylaxis of recurrent urinary tract infections, co-Trimoxazole is not indicated for prophylactic use.&nbsp;&nbsp;</p><p style="margin-left:18.0pt; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]-->&sect; <!--[endif]--><em>Respiratory tract infections: </em>Co-Trimoxazole may be used as second line therapy in chronic obstructive airways disease or other respiratory tract infections, including acute otitis media where sensitivity has been demonstrated or is highly probable.</p><p style="margin-left:18.0pt; text-align:justify">(Co-Trimoxazole is not indicated for prophylactic or prolonged administration in otitis media).</p><p style="margin-left:18.0pt; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]-->&sect; <!--[endif]-->Treatment and prevention of <em>Pneumocystis jirovecii pneumonitis (PJP)</em>.</p><p style="margin-left:18.0pt; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]-->&sect; <!--[endif]-->Co-Trimoxazole may be used in the management of other serious conditions such as nocardiasis, toxoplasmosis and brucellosis.</p><p style="text-align:justify">Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><strong><u>Posology:</u></strong></p><p style="text-align:justify"><strong><u>Standard dosage recommendations for acute infections</u></strong></p><p style="text-align:justify"><em>Children aged 12 years and under (infants (&gt;6 weeks to &lt;2 years old) and children (&gt;2 to &lt;12 years old)</em></p><p style="text-align:justify">The standard dosage for children is equivalent to approximately 6 mg trimethoprim and 30 mg sulphamethoxazole per kg body weight per day, given in two equally divided doses. The schedules for children are according to the child&#39;s age and provided in the table below:</p><table cellspacing="0" cellpadding="0" border="1" style="width:396.0pt"><tbody><tr><td colspan="2" style="vertical-align:top; width:100.0%"><p style="text-align:justify"><strong>STANDARD DOSAGE</strong></p></td></tr><tr><td style="vertical-align:top; width:43.18%"><p style="text-align:justify"><strong>Age</strong></p></td><td style="vertical-align:top; width:56.82%"><p style="text-align:justify"><strong>Paediatric Suspension</strong></p></td></tr><tr><td style="vertical-align:top; width:43.18%"><p style="text-align:justify">6 to 12 years</p></td><td style="vertical-align:top; width:56.82%"><p style="text-align:justify">10 ml every 12 hours</p></td></tr><tr><td style="vertical-align:top; width:43.18%"><p style="text-align:justify">6 months to 5 years</p></td><td style="vertical-align:top; width:56.82%"><p style="text-align:justify">5 ml every 12 hours</p></td></tr><tr><td style="vertical-align:top; width:43.18%"><p style="text-align:justify">6 weeks to 5 months</p></td><td style="vertical-align:top; width:56.82%"><p style="text-align:justify">2.5 ml every 12 hours</p></td></tr></tbody></table><p style="text-align:justify">Treatment should be continued until the patient has been symptom free for two days; the majority will require treatment for at least 5 days. If clinical improvement is not evident after 7 days therapy, the patient should be reassessed.</p><p style="text-align:justify">As an alternative to Standard Dosage for acute uncomplicated lower urinary tract infections, short-term therapy of 1 to 3 days duration has been shown to be effective.</p><p style="text-align:justify"><strong>Impaired hepatic function:</strong></p><p style="text-align:justify">No data are available relating to dosage in patients with impaired hepatic function.</p><p style="text-align:justify"><strong>Impaired renal function:</strong></p><p style="text-align:justify"><strong><u>Dosage recommendation</u></strong><strong>:</strong></p><p style="text-align:justify"><em>Adults (&gt;18 years old) and children over 12 years old (&gt;12 to &lt;18 years old):</em></p><table cellspacing="0" cellpadding="0" border="1" style="width:396.0pt"><tbody><tr><td style="vertical-align:top; width:43.18%"><p style="text-align:justify"><strong>Creatinine Clearance (ml/min)</strong></p></td><td style="vertical-align:top; width:56.82%"><p style="text-align:justify"><strong>Recommended Dosage</strong></p></td></tr><tr><td style="vertical-align:top; width:43.18%"><p style="text-align:justify">&gt;30</p></td><td style="vertical-align:top; width:56.82%"><p style="text-align:justify">10 ml every 12 hours</p></td></tr><tr><td style="vertical-align:top; width:43.18%"><p style="text-align:justify">15 to 30</p></td><td style="vertical-align:top; width:56.82%"><p style="text-align:justify">5 ml every 12 hours</p></td></tr><tr><td style="vertical-align:top; width:43.18%"><p style="text-align:justify">&lt;15</p></td><td style="vertical-align:top; width:56.82%"><p style="text-align:justify">Not recommended</p></td></tr></tbody></table><p style="text-align:justify">No information available for children aged 12 years and under with renal failure. See section 5.2 for the pharmacokinetics in the paediatric population with normal renal function of both components of Co-Trimoxazole .</p><p style="text-align:justify">Measurements of plasma concentration of sulphamethoxazole at intervals of 2 to 3 days are recommended in samples obtained 12 hours after administration of Co-Trimoxazole. If the concentration of total sulphamethoxazole exceeds 150 microgram/ml then treatment should be interrupted until the value falls below 120 microgram/ml.</p><p style="text-align:justify"><strong><u>Pneumocystis jirovecii pneumonitis:</u></strong></p><p style="text-align:justify"><em>Treatment -&nbsp;Children aged 12 years and under (infants (&gt;6 weeks to &lt;2 years old) and children (&gt;2 to &lt;12 years old):</em></p><p style="text-align:justify">A higher dosage is recommended, using 20 mg trimethoprim and 100 mg sulphamethoxazole per kg of body weight per day (see table below) in two or more divided doses for two weeks. The aim is to obtain peak plasma or serum levels of trimethoprim of&nbsp;<u>greater than or equal to</u>&nbsp;5 microgram/ml (verified in patients receiving 1-hour infusions of intravenous Co-Trimoxazole) (see section 4.8).</p><p style="text-align:justify"><em>Prevention -&nbsp;Children aged 12 years and under (infants (&gt;6 weeks to &lt;2 years old) and children (&gt;2 to &lt;12 years old):</em></p><p style="text-align:justify">&nbsp;</p><table cellspacing="0" cellpadding="0" border="1" style="width:400.5pt"><tbody><tr><td style="vertical-align:top; width:33.64%"><p style="text-align:justify"><strong>Age</strong></p></td><td style="vertical-align:top; width:66.36%"><p style="text-align:justify"><strong>Paediatric Suspension</strong></p></td></tr><tr><td style="vertical-align:top; width:33.64%"><p style="text-align:justify">6 to 12 years</p></td><td style="vertical-align:top; width:66.36%"><p style="text-align:justify">10 ml every 12 hours, seven days per week</p></td></tr><tr><td style="vertical-align:top; width:33.64%"><p style="text-align:justify">6 to 12 years</p></td><td style="vertical-align:top; width:66.36%"><p style="text-align:justify">10 ml every 12 hours, three times per week on alternative days</p></td></tr><tr><td style="vertical-align:top; width:33.64%"><p style="text-align:justify">6 to 12 years</p></td><td style="vertical-align:top; width:66.36%"><p style="text-align:justify">10 ml every 12 hours, three times per week on consecutive days</p></td></tr><tr><td style="vertical-align:top; width:33.64%"><p style="text-align:justify">6 to 12 years</p></td><td style="vertical-align:top; width:66.36%"><p style="text-align:justify">20 ml once a day, three times per week on consecutive days</p></td></tr><tr><td style="vertical-align:top; width:33.64%"><p style="text-align:justify">6 months to 5 years</p></td><td style="vertical-align:top; width:66.36%"><p style="text-align:justify">5 ml every 12 hours, seven days per week</p></td></tr><tr><td style="vertical-align:top; width:33.64%"><p style="text-align:justify">6 months to 5 years</p></td><td style="vertical-align:top; width:66.36%"><p style="text-align:justify">5 ml every 12 hours, three times per week on alternative days</p></td></tr><tr><td style="vertical-align:top; width:33.64%"><p style="text-align:justify">6 months to 5 years</p></td><td style="vertical-align:top; width:66.36%"><p style="text-align:justify">5 ml every 12 hours, three times per week on consecutive days</p></td></tr><tr><td style="vertical-align:top; width:33.64%"><p style="text-align:justify">6 months to 5 years</p></td><td style="vertical-align:top; width:66.36%"><p style="text-align:justify">10 ml once a day, three times per week on consecutive days</p></td></tr><tr><td style="vertical-align:top; width:33.64%"><p style="text-align:justify">6 weeks to 5 months</p></td><td style="vertical-align:top; width:66.36%"><p style="text-align:justify">2.5 ml every 12 hours, seven days per week</p></td></tr><tr><td style="vertical-align:top; width:33.64%"><p style="text-align:justify">6 weeks to 5 months</p></td><td style="vertical-align:top; width:66.36%"><p style="text-align:justify">2.5 ml every 12 hours, three times per week on alternative days</p></td></tr><tr><td style="vertical-align:top; width:33.64%"><p style="text-align:justify">6 weeks to 5 months</p></td><td style="vertical-align:top; width:66.36%"><p style="text-align:justify">2.5 ml every 12 hours, three times per week on consecutive days</p></td></tr><tr><td style="vertical-align:top; width:33.64%"><p style="text-align:justify">6 weeks to 5 months</p></td><td style="vertical-align:top; width:66.36%"><p style="text-align:justify">5 ml once a day, three times per week on consecutive days</p></td></tr></tbody></table><p style="text-align:justify">The daily dose given on a treatment day approximates to 150 mg trimethoprim/m<sup>2</sup>/day and 750 mg sulphamethoxazole/m<sup>2</sup>/day. The total daily dose should not exceed 320 mg trimethoprim and 1600 mg sulphamethoxazole.</p><p style="text-align:justify"><strong>Nocardiosis </strong></p><p style="text-align:justify">There is no consensus on the most appropriate dosage. Adult doses of 480 mg trimethoprim/2400 mg sulphamethoxazole to 640 mg trimethoprim/3200 mg sulphamethoxazole daily for up to three months have been used.</p><p style="text-align:justify"><strong>Brucellosis </strong></p><p style="text-align:justify">It may be advisable to use a higher than standard dosage initially. Treatment should continue for a period of at least four weeks and repeated courses may be beneficial. Co-trimoxazole should be given in combination with other agents in line with national treatment guidelines.</p><p style="text-align:justify"><strong>Toxoplasmosis </strong></p><p style="text-align:justify">There is no consensus on the most appropriate dosage for the treatment or prophylaxis of this condition. The decision should be based on clinical experience. Doses of 480 mg or 960 mg of trimethoprim - sulphamethoxazole twice daily for three months have been used for prophylaxis and 40 mg/kg/day or 120 mg/kg/day for a mean of 25 days for the treatment of toxoplasmosis in patients with HIV.</p><p style="text-align:justify"><strong><u>Method of administration </u></strong></p><p style="text-align:justify">Oral</p><p style="text-align:justify">It may be preferable to take co-trimoxazole with some food or drink to minimise the possibility of gastrointestinal disturbances.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Co-trimoxazole Paediatric suspension is contraindicated in patients with:
	Hypersensitivity to the active substance(s) sulphonamides, trimethoprim or to any of the excipients listed in section 6.1.
	Severe renal insufficiency where repeated measurements of the plasma drug concentration cannot be performed.
	Severe impairment of liver function.
	A history of drug-induced immune thrombocytopenia with use of trimethoprim and/or sulphonamides.
	Acute porphyria.
	Co-trimoxazole should not be given to infants during the first 6 weeks of life.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Fatalities, although very rare, have occurred due to severe reactions including Stevens-Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, aplastic anaemia, other blood dyscrasias and hypersensitivity of the respiratory tract.</p><p style="text-align:justify"><strong><u>Life threatening adverse reaction</u></strong></p><p style="margin-left:9.0pt; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]-->&sect; <!--[endif]-->Life-threatening cutaneous reactions Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been reported with the use of co-trimoxazole.</p><p style="margin-left:9.0pt; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]-->&sect; <!--[endif]-->Patients should be advised of the signs and symptoms and monitored closely for skin reactions. The highest risk for occurrence of SJS or TEN is within the first weeks of treatment.</p><p style="margin-left:9.0pt; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]-->&sect; <!--[endif]-->If symptoms or signs of SJS or TEN (e.g. progressive skin rash often with blisters or mucosal lesions) are present, co-trimoxazole treatment should be discontinued (see section 4.8).</p><p style="margin-left:9.0pt; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]-->&sect; <!--[endif]-->The best results in managing SJS and TEN come from early diagnosis and immediate discontinuation of any suspect drug. Early withdrawal is associated with a better prognosis.</p><p style="margin-left:9.0pt; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]-->&sect; <!--[endif]-->If the patient has developed SJS or TEN with the use of co-trimoxazole, co-trimoxazole must not be re-started in this patient at any time.</p><p style="text-align:justify"><strong><u>Elderly patients</u></strong></p><p style="text-align:justify">Particular care is always advisable when treating elderly patients because, as a group, they are more susceptible to adverse reactions and more likely to suffer serious effects as a result particularly when complicating conditions exist, e.g. impaired kidney and/or liver function and/or concomitant use of other drugs.</p><p style="text-align:justify"><strong><u>Patients with renal impairment</u></strong></p><p style="text-align:justify">For patients with known renal impairment special measures should be adopted (see section 4.2).</p><p style="text-align:justify"><strong><u>Urinary output</u></strong></p><p style="text-align:justify">An adequate urinary output should be maintained at all times. Evidence of crystalluria in vivo is rare, although sulphonamide crystals have been noted in cooled urine from treated patients. In patients suffering from hypoalbuminaemia the risk may be increased.</p><p style="text-align:justify"><strong><u>Folate </u></strong></p><p style="text-align:justify">Regular monthly blood counts are advisable when co-trimoxazole is given for long periods, or to folate deficient patients or to the elderly; since there exists a possibility of asymptomatic changes in haematological laboratory indices due to lack of available folate. Supplementation with folinic acid may be considered during treatment but this should be initiated with caution due to possible interference with antimicrobial efficacy (see section 4.5).</p><p style="text-align:justify"><strong><u>Patients with glucose-6-phosphate dehydrogenase deficiency</u></strong></p><p style="text-align:justify">In glucose-6-phosphate dehydrogenase (G-6-PD) deficient patients, haemolysis may occur.</p><p style="text-align:justify"><strong><u>Patients with severe atopy or bronchial asthma</u></strong></p><p style="text-align:justify">Co-trimoxazole should be given with caution to patients with severe atopy or bronchial asthma.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong><u>Treatment of streptococcal pharyngitis due to Group A beta-haemolytic streptococci</u></strong></p><p style="text-align:justify">Co-trimoxazole should not be used in the treatment of streptococcal pharyngitis due to Group A &beta;-haemolytic streptococci; eradication of these organisms from the oropharynx is less effective than with penicillin.</p><p style="text-align:justify"><strong><u>Phenylalanine metabolism</u></strong></p><p style="text-align:justify">Trimethoprim has been noted to impair phenylalanine metabolism but this is of no significance in phenylketonuric patients on appropriate dietary restriction.</p><p style="text-align:justify"><strong><u>Patients with or at risk of porphyria</u></strong></p><p style="text-align:justify">The administration of co-trimoxazole to patients known or suspected to be at risk of porphyria should be avoided. Both trimethoprim and sulphonamides (although not specifically sulphamethoxazole) have been associated with clinical exacerbation of porphyria.</p><p style="text-align:justify"><strong><u>Patients with hyperkalaemia and hyponatraemia</u></strong></p><p style="text-align:justify">Close monitoring of serum potassium is warranted in patients at risk of hyperkalaemia and hyponatraemia.</p><p style="text-align:justify"><strong><u>Metabolic acidosis&nbsp; </u></strong></p><p style="text-align:justify">Co-trimoxazole has been associated with metabolic acidosis when other possible underlying causes have been excluded. Close monitoring is always advisable when metabolic acidosis is suspected.</p><p style="text-align:justify"><strong><u>Patients with serious haematological disorders</u></strong></p><p style="text-align:justify">Except under careful supervision co-trimoxazole should not be given to patients with serious haematological disorders (see section 4.8). Co-trimoxazole has been given to patients receiving cytotoxic therapy with little or no additional effect on the bone marrow or peripheral blood.</p><p style="text-align:justify">Patients with rare hereditary problems of fructose intolerance should not take this medicine (see section 2).</p><p style="text-align:justify"><strong>Trimol</strong> Suspension contains:</p><p style="margin-left:18.0pt; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]-->&sect; <!--[endif]-->Methyl paraben and propyl paraben, which may cause allergic reactions (possibly delayed).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><u>Diuretics (thiazides)</u>: in elderly patients concurrently receiving diuretics, mainly thiazides, there appears to be an increased risk of thrombocytopenia with or without purpura.</p><p style="text-align:justify"><u>Pyrimethamine:&nbsp;</u>occasional reports suggest that patients receiving pyrimethamine at doses in excess of 25 mg weekly may develop megaloblastic anaemia should co-trimoxazole be prescribed concurrently.</p><p style="text-align:justify"><u>Zidovudine</u>: in some situations, concomitant treatment with zidovudine may increase the risk of haematological adverse reactions to co-trimoxazole. If concomitant treatment is necessary, consideration should be given to monitoring of haematological parameters.</p><p style="text-align:justify"><u>Lamivudine:</u>&nbsp;administration of trimethoprim/sulphamethoxazole 160 mg/800 mg (co-trimoxazole) causes a 40% increase in lamivudine exposure because of the trimethoprim component. Lamivudine has no effect on the pharmacokinetics of trimethoprim or sulphamethoxazole.</p><p style="text-align:justify"><u>Warfarin</u>: co-trimoxazole has been shown to potentiate the anticoagulant activity of warfarin via stereo-selective inhibition of its metabolism. Sulphamethoxazole may displace warfarin from plasma-albumin protein-binding sites&nbsp;<em>in vitro</em>. Careful control of the anticoagulant therapy during treatment with Co-trimoxazole is advisable.</p><p style="text-align:justify"><u>Phenytoin</u>: co-trimoxazole prolongs the half-life of phenytoin and if co-administered excessive phenytoin effect. Close monitoring of the patient&#39;s condition and serum phenytoin levels are advisable.</p><p style="text-align:justify">Interaction with&nbsp;<u>sulphonylurea hypoglycaemic agents&nbsp;</u>is uncommon but potentiation has been reported.</p><p style="text-align:justify"><u>Rifampicin:</u>&nbsp;concurrent use of rifampicin and Co-trimoxazole results in a shortening of the plasma half-life of trimethoprim after a period of about one week. This is not thought to be of clinical significance.</p><p style="text-align:justify"><u>Cyclosporin</u>: reversible deterioration in renal function has been observed in patients treated with co-trimoxazole and cyclosporin following renal transplantation.</p><p style="text-align:justify">When trimethoprim is administered simultaneously with drugs that form cations at physiological pH, and are also partly excreted by active renal secretion (e.g.&nbsp;<u>procainamide, amantadine</u>), there is the possibility of competitive inhibition of this process which may lead to an increase in plasma concentration of one or both of the drugs.</p><p style="text-align:justify"><u>Digoxin</u>: concomitant use of trimethoprim with digoxin has been shown to increase plasma digoxin levels in a proportion of elderly patients.</p><p style="text-align:justify"><u>Hyperkalaemia:&nbsp;</u>caution should be exercised in patients taking any other drugs that can cause hyperkalaemia, for example ACE inhibitors, angiotensin receptor blockers and potassium-sparing diuretics such as spironolactone. Concomitant use of trimethoprim-sulphamethoxazole (co-trimoxazole) may result in clinically relevant hyperkalaemia. <u>Azathioprine:</u>&nbsp;There are conflicting clinical reports of interactions, resulting in serious haematological abnormalities, between azathioprine and co-trimoxazole.</p><p style="text-align:justify"><u>Methotrexate:&nbsp;</u>co-trimoxazole may increase the free plasma levels of methotrexate. If Co-trimoxazole is considered appropriate therapy in patients receiving other anti-folate drugs such as methotrexate, a folate supplement should be considered. (see section 4.4)</p><p style="text-align:justify"><u>Repaglinide</u>: trimethoprim may increase the exposure of repaglinide which may result in hypoglycaemia.</p><p style="text-align:justify"><u>Folinic acid</u>: folinic acid supplementation has been shown to interfere with the antimicrobial efficacy of trimethoprim-sulphamethoxazole. This has been observed in&nbsp;<em>Pneumocystis jiroveci pneumonia</em>&nbsp;prophylaxis and treatment.</p><p style="text-align:justify"><u>Contraceptives</u>: oral contraceptive failures have been reported with antibiotics. The mechanism of this effect has not been elucidated. Women on treatment with antibiotics should temporarily use a barrier method in addition to the oral contraceptive, or choose another method of contraception<u>.</u></p><p style="text-align:justify"><strong><u>Interaction with laboratory tests</u></strong><strong>:</strong></p><p style="text-align:justify">Trimethoprim interferes with assays for serum methotrexate when dihydrofolate reductase from&nbsp;<em>Lactobacillus</em>&nbsp;<em>casei&nbsp;</em>is used in the assay. No interference occurs if methotrexate is measured by radio-immune assay.</p><p style="text-align:justify">Trimethoprim may interfere with the estimation of serum/plasma creatinine when the alkaline picrate reaction is used. This may result in overestimation of serum/plasma creatinine of the order of 10%.</p><p style="margin-left:0cm; margin-right:0cm; text-align:justify">Functional inhibitation of the renal tubular secretion of creatinine may produce a spurious fall in the estimated rate of creatinine clearance.</p><p>&nbsp;</p><p>&nbsp;<p>&nbsp;</p></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><strong><u>Pregnancy </u></strong></p><p style="text-align:justify">Trimethoprim and sulphamethoxazole cross the placenta and their safety in human pregnancy has not been established. Trimethoprim is a folate antagonist and, in animal studies, both agents have been shown to cause foetal abnormalities (see section 5.3). Case-control studies have shown that there may be an association between exposure to folate antagonists and birth defects in humans. Therefore Co-trimoxazole should be avoided in pregnancy, particularly in the first trimester, unless the potential benefit to the mother outweighs the potential risk to the foetus; folate supplementation should be considered if Co-trimoxazole is used in pregnancy</p><p style="text-align:justify">Sulphamethoxazole competes with bilirubin for binding to plasma albumin. As significant maternally derived drug levels persist for several days in the newborn, there may be a risk of precipitating or exacerbating neonatal hyperbilirubinaemia, with an associated theoretical risk of kernicterus, when Co-trimoxazole is administered to the mother near the time of delivery. This theoretical risk is particularly relevant in infants at increased risk of hyperbilirubinaemia, such as those who are preterm and those with glucose-6- phosphate dehydrogenase deficiency.</p><p style="text-align:justify"><strong><u>Breast Feeding </u></strong></p><p style="margin-left:0cm; margin-right:0cm; text-align:justify">Trimethoprim and sulphamethoxazole are excreted in breast milk. Administration of Co-trimoxazole should be avoided in late pregnancy and in lactating mothers where the mother or infant has, or is at particular risk of developing, hyperbilirubinaemia. Additionally, administration of Co-trimoxazole should be avoided in infants younger than eight weeks in view of the predisposition of young infants to hyperbilirubinaemia.</p><p style="margin-left:0cm; margin-right:0cm; text-align:justify">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Effects on the ability to drive and operate machinery in patients taking this medicine have not been studied.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">As co-trimoxazole contains trimethoprim and a sulphonamide the type and frequency of adverse reactions associated with such compounds are expected to be consistent with extensive historical experience.</p><p style="text-align:justify">Data from large published clinical trials were used to determine the frequency of very common to rare adverse events. Very rare adverse events were primarily determined from post-marketing experience data and therefore refer to reporting rate rather than a &quot;true&quot; frequency. In addition, adverse events may vary in their incidence depending on the indication.</p><p style="text-align:justify">The following convention has been used for the classification of adverse events in terms of frequency:</p><p style="margin-left:18.0pt; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]-->&sect; <!--[endif]-->Very common &ge;1/10,</p><p style="margin-left:18.0pt; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]-->&sect; <!--[endif]-->Common &ge;1/100 and &lt;1/10,</p><p style="margin-left:18.0pt; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]-->&sect; <!--[endif]-->Uncommon &ge;1/1000 and &lt;1/100,</p><p style="margin-left:18.0pt; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]-->&sect; <!--[endif]-->Rare &ge;1/10,000 and &lt;1/1000,</p><p style="margin-left:18.7pt; margin-right:0cm; text-align:justify; text-indent:-9.35pt"><!--[if !supportLists]-->&sect; <!--[endif]-->Very rare &lt;1/10,000.</p><table cellspacing="0" cellpadding="0" border="1" style="width:400.5pt"><tbody><tr><td style="vertical-align:top; width:30.34%"><p style="text-align:justify"><strong>System Organ Class</strong></p></td><td style="vertical-align:top; width:19.1%"><p style="text-align:justify"><strong>Frequency</strong></p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify"><strong>Side effects</strong></p></td></tr><tr><td style="height:23.0pt; vertical-align:top; width:30.34%"><p style="text-align:justify">Infections and infestations</p></td><td style="height:23.0pt; vertical-align:top; width:19.1%"><p style="text-align:justify">Common</p></td><td style="height:23.0pt; vertical-align:top; width:50.56%"><p style="text-align:justify">Overgrowth fungal.</p></td></tr><tr><td style="vertical-align:top; width:30.34%"><p style="text-align:justify">Blood and lymphatic system disorders</p></td><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Very rare</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Leukopenia, neutropenia, thrombocytopenia, agranulocytosis, anaemia megaloblastic, aplastic anaemia, haemolytic anaemia, methaemoglobinaemia, eosinophilia, purpura, haemolysis in certain susceptible G-6-PD deficient patients.</p></td></tr><tr><td style="vertical-align:top; width:30.34%"><p style="text-align:justify">Immune system disorders</p></td><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Very rare</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Serum sickness, anaphylactic reaction, allergic myocarditis, hypersensitivity vasculitis resembling Henoch-Schoenlein purpura, periarteritis nodosa, systemic lupus erythematosus.</p><p style="text-align:justify">Severe hypersensitivity reactions associated with PJP* including rash, pyrexia, neutropenia, thrombocytopenia, hepatic enzyme increased, hyperkalaemia, hyponatraemia, rhabdomyolysis</p></td></tr><tr><td rowspan="2" style="vertical-align:top; width:30.34%"><p style="text-align:justify">Metabolism and nutrition disorders</p></td><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Very common</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Hyperkalaemia.</p></td></tr><tr><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Very rare</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Hypoglycaemia, hyponatraemia, decreased appetite, metabolic acidosis</p></td></tr><tr><td rowspan="2" style="vertical-align:top; width:30.34%"><p style="text-align:justify">Psychiatric disorders</p></td><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Very rare</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Depression, hallucination.</p></td></tr><tr><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Not known</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Psychotic disorder</p></td></tr><tr><td rowspan="2" style="vertical-align:top; width:30.34%"><p style="text-align:justify">Nervous system disorders</p></td><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Common</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Headache.</p></td></tr><tr><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Very rare</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Meningitis aseptic *, seizure, neuropathy peripheral, ataxia, dizziness.</p></td></tr><tr><td style="vertical-align:top; width:30.34%"><p style="text-align:justify">Ear and labrynth disroders</p></td><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Very rare</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Vertigo, tinnitus</p></td></tr><tr><td style="vertical-align:top; width:30.34%"><p style="text-align:justify">Eye disorders</p></td><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Very rare</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Uveitis.</p></td></tr><tr><td style="vertical-align:top; width:30.34%"><p style="text-align:justify">Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Very rare</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Cough*, dyspnoea *, lung infiltration*.</p></td></tr><tr><td rowspan="3" style="vertical-align:top; width:30.34%"><p style="text-align:justify">Gastrointestinal disorders</p></td><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Common</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Nausea, diarrhoea.</p></td></tr><tr><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Uncommon</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Vomiting.</p></td></tr><tr><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Very rare</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Glossitis, stomatitis, pseudomembranous, colitis, pancreatitis.</p></td></tr><tr><td style="vertical-align:top; width:30.34%"><p style="text-align:justify">Hepatobiliary disorders</p></td><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Very rare</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Jaundice cholestatic *, hepatic necrosis*</p><p style="text-align:justify">Transaminases increased, blood bilirubin increased.</p></td></tr><tr><td rowspan="2" style="vertical-align:top; width:30.34%"><p style="text-align:justify">Skin and subcutaneous tissue disorders*</p></td><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Common</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Rash.</p></td></tr><tr><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Very rare</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Photosensitivity reaction, angioedema, dermatitis exfoliative, fixed drug eruption, erythema multiforme, Stevens-Johnson syndrome (SJS)*, toxic epidermal necrolysis (TEN)*.</p></td></tr><tr><td style="vertical-align:top; width:30.34%"><p style="text-align:justify">Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Very rare</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Arthralgia, myalgia.</p></td></tr><tr><td style="vertical-align:top; width:30.34%"><p style="text-align:justify">Renal and urinary disorders</p></td><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Very rare</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Renal impairment (sometimes reported as renal failure), tubulointerstitial nephritis.</p></td></tr><tr><td style="vertical-align:top; width:30.34%"><p style="text-align:justify">General disorders and administration site conditions</p></td><td style="vertical-align:top; width:19.1%"><p style="text-align:justify">Very rare</p></td><td style="vertical-align:top; width:50.56%"><p style="text-align:justify">Pyrexia.</p></td></tr></tbody></table><p style="text-align:justify">* see description of selected adverse reactions</p><p style="text-align:justify"><strong><u>Description of selected adverse reactions </u></strong></p><p style="text-align:justify"><strong>Aseptic meningitis </strong></p><p style="text-align:justify">Aseptic meningitis was rapidly reversible on withdrawal of the drug, but recurred in a number of cases on re-exposure to either co-trimoxazole or to trimethoprim alone.</p><p style="text-align:justify"><strong>Pulmonary hypersensitivity reactions&nbsp; </strong></p><p style="text-align:justify">Cough, dyspnoea and lung infiltration may be early indicators of respiratory hypersensitivity which, while very rare, has been fatal.</p><p style="text-align:justify"><strong>Severe cutaneous adverse reactions (SCARs) </strong></p><p style="text-align:justify">Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been reported (see section 4.4).</p><p style="text-align:justify"><strong>Hepatobiliary disorders </strong></p><p style="text-align:justify">Jaundice cholestatic and hepatic necrosis may be fatal.</p><p style="text-align:justify"><strong>Effects associated with Pneumocystis jirovecii (P. carinii) Pneumonitis (PJP) management </strong></p><p style="text-align:justify">At the high dosages used for PJP management severe hypersensitivity reactions have been reported, necessitating cessation of therapy. Severe hypersensitivity reactions have been reported in PJP patients on re-exposure to trimethoprim-sulphamethoxazole, sometimes after a dosage interval of a few days. Rhabdomyolysis has been reported in HIV positive patients receiving co-trimoxazole for prophylaxis or treatment of PJP.</p><p style="text-align:justify"><strong><u>&nbsp;</u></strong></p><p><strong><u>To report any side effect(s):</u></strong></p><p style="margin-left:9.0pt; text-indent:-9.0pt">&middot; &nbsp;<strong>Saudi Arabia:</strong></p><p style="margin-left:9.0pt"><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p style="margin-left:9.0pt"><strong>Fax: </strong>+966-11-205-7662</p><p style="margin-left:9.0pt"><strong>Call NPC at </strong>+966-11-2038222, Exts: 2317-2356-2340</p><p style="margin-left:9.0pt"><strong>Reporting Hotline: </strong>19999</p><p style="margin-left:9.0pt"><strong>E-mail: </strong>npc.drug@sfda.gov.sa</p><p style="margin-left:9.0pt"><strong>Website: </strong>www.sfda.gov.sa/npc</p><p style="margin-left:9.0pt; text-align:justify; text-indent:-9.0pt">&middot; &nbsp;<strong>Other GCC States: </strong>Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><strong><u>Symptoms </u></strong></p><p style="text-align:justify">Nausea, vomiting, dizziness and confusion are likely signs/symptoms of overdose. Bone marrow depression has been reported in acute trimethoprim overdose.</p><p style="text-align:justify"><strong><u>Management </u></strong></p><p style="text-align:justify">Dependent on the status of renal function administration of fluids is recommended if urine output is low.</p><p style="text-align:justify">Both trimethoprim and active sulphamethoxazole are moderately dialysable by haemodialysis. Peritoneal dialysis is not effective.</p><p style="text-align:justify">In cases of known, suspected or accidental overdose, stop therapy.</p><p>Acidification of the urine will increase the elimination of trimethoprim. Inducing diuresis plus alkalinisation of urine will enhance the elimination of sulphamethoxazole. Alkalinisation will reduce the rate of elimination of trimethoprim. Calcium folinate (5 to 10 mg/day) will reverse any folate deficiency effect of trimethoprim on the bone marrow should this occur. General supportive measures are recommended</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table cellspacing="0" cellpadding="0" border="1" style="width:678px"><tbody><tr><td style="vertical-align:top"><p style="text-align:justify"><strong>Pharmacotherapeutic group:&nbsp;</strong>antibacterials for systemic use &ndash; sulfonamides and trimethoprim&nbsp;Combinations of sulfonamides and trimethoprim, incl. derivatives;</p><p style="text-align:justify"><strong>ATC code: </strong>J01EE01</p><p style="text-align:justify"><strong><u>Mechanism of action</u></strong></p><p style="text-align:justify">Sulphamethoxazole competitively inhibits the utilisation of para-aminobenzoic acid in the synthesis of dihydrofolate by the bacterial cell resulting in bacteriostasis. Trimethoprim reversibly inhibits bacterial dihydrofolate reductase (DHFR), an enzyme active in the folate metabolic pathway converting dihydrofolate to tetrahydrofolate. Depending on the conditions the effect may be bactericidal. Thus trimethoprim and sulphamethoxazole block two consecutive steps in the biosynthesis of purines and therefore nucleic acids essential to many bacteria. This action produces marked potentiation of activity in vitro between the two agents.</p><p style="text-align:justify">Trimethoprim binds to plasmodial DHFR but less tightly than to the bacterial enzyme. The affinity of trimethoprim for mammalian DHFR is some 50,000 times less than for the corresponding bacterial enzyme.</p><p style="text-align:justify"><strong><u>Resistance</u></strong></p><p style="text-align:justify">In vitro studies have shown that bacterial resistance can develop more slowly with both sulphamethoxazole and trimethoprim in combination that with either sulphamethoxazole or trimethoprim alone.</p><p style="text-align:justify">Resistance to sulphamethoxazole may occur by different mechanisms. Bacterial mutations cause an increase the concentration of PABA and thereby out-compete with sulphamethoxazole resulting in a reduction of the inhibitory effect on dihydropteroate synthetase enzyme. Another resistance mechanism is plasmid-mediated and results from production of an altered dihydropteroate synthetase enzyme, with reduced affinity for sulphamethoxazole compared to the wild-type enzyme.</p><p style="text-align:justify">Resistance to trimethoprim occurs through a plasmid-mediated mutation which results in production of an altered dihydrofolate reductase enzyme having a reduced affinity for trimethoprim compared to the wild-type enzyme.</p><p style="text-align:justify"><strong><u>Susceptibility testing breakpoints</u></strong></p><p style="text-align:justify">Testing of trimethoprim sulphamethoxazole was performed using the common dilution series to assess the Minimum Inhibitory Concentration (MIC). The MIC breakpoints for resistance are those recommended by CLSI (Clinical and Laboratory Standards Institute &ndash; formerly the National Committee for Clinical Laboratory Standards (NCCLS) and EUCAST guidelines.</p><p style="text-align:justify"><strong><u>Pharmacodynamic effects</u></strong></p><p style="text-align:justify">The majority of common pathogenic bacteria are sensitive in vitro to trimethoprim and sulphamethoxazole at concentrations well below those reached in blood, tissue fluids and urine after the administration of recommended doses. In common with other antimicrobial agents in vitro activity does not necessarily imply that clinical efficacy had been demonstrated. These organisms include:</p><table cellspacing="0" cellpadding="0" border="1" style="width:98.1%"><tbody><tr><td style="vertical-align:top; width:100.0%"><p style="text-align:justify"><strong>Gram Negative</strong></p></td></tr><tr><td style="vertical-align:top; width:100.0%"><p style="text-align:justify"><em>Brucella spp.</em></p><p style="text-align:justify"><em>Citrobacter spp.</em></p><p style="text-align:justify"><em>Escherichia coli (including ampicillin-resistant strains)</em></p><p style="text-align:justify"><em>Haemophilus ducreyi</em></p><p style="text-align:justify"><em>Haemophilus influenzae (including ampicillin-resistant strains)</em></p><p style="text-align:justify"><em>Klebsiella/Enterobacter spp.</em></p><p style="text-align:justify"><em>Legionella pneumophila</em></p><p style="text-align:justify"><em>Morganella morganii (previously Proteus morganii)</em></p><p style="text-align:justify"><em>Neisseria spp.</em></p><p style="text-align:justify"><em>Proteus spp.</em></p><p style="text-align:justify"><em>Providencia spp. (including previously Proteus rettgeri)</em></p><p style="text-align:justify"><em>Certain Pseudomonas spp. except aeruginosa</em></p><p style="text-align:justify"><em>Salmonella spp. including&nbsp;</em>S.&nbsp;<em>typhi and paratyphi.</em></p><p style="text-align:justify"><em>Serratia marcescens.</em></p><p style="text-align:justify"><em>Shingella spp.</em></p><p style="text-align:justify"><em>Vibrio cholerae</em></p><p style="text-align:justify"><em>Yersinia spp.</em></p></td></tr><tr><td style="vertical-align:top; width:100.0%"><p style="text-align:justify"><strong>Gram positive</strong></p></td></tr><tr><td style="vertical-align:top; width:100.0%"><p style="text-align:justify"><em>Listeria monocytogenes.</em></p><p style="text-align:justify"><em>Nocardia spp.</em></p><p style="text-align:justify"><em>Staohylococcus aureus.</em></p><p style="text-align:justify"><em>Staphylococcus epidermidis and saprophyticus</em></p><p style="text-align:justify"><em>Enterococcus faecalis.</em></p><p style="text-align:justify"><em>Streptococcus pneumoni ae.</em></p><p style="text-align:justify"><em>Streptococcus viridans.</em></p></td></tr></tbody></table><p style="text-align:justify">Many strains of Bacteroides fragilis are sensitive. Some strains of&nbsp;<em>Campylobacter fetus subsp. Jejuni</em>&nbsp;and chlamydia are sensitive without evidence of synergy. Some varieties of non-tuberculous mycobacteria are sensitive to sulphamethoxazole but not trimethoprim. Mycoplasmas, Ureaplasma urealyticum, Mycobacterium tuberculosis and Treponema pallidum are insensitive.</p><p style="text-align:justify">Satisfactory sensitivity testing is achieved only with recommended media free from inhibitory substances especially thymidine and thymine.</p></td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><strong><u>Absorption:</u></strong></p><p style="text-align:justify">After oral administration trimethoprim and sulphamethoxazole are rapidly and nearly completely absorbed. The presence of food does not appear to delay absorption. Peak levels in the blood occur between one and four hours after ingestion and the level attained is dose related. Effective levels persist in the blood for up to 24 hours after a therapeutic dose. Steady state levels in adults are reached after dosing for 2-3 days. Neither component has an appreciable effect on the concentrations achieved in the blood by the other.</p><p style="text-align:justify"><strong><u>Distribution:</u></strong></p><p style="text-align:justify">Approximately 50% of trimethoprim in the plasma is protein bound</p><p style="text-align:justify">Tissue levels of trimethoprim are generally higher than corresponding plasma levels, the lungs and kidneys showing especially high concentrations. Trimethoprim concentrations exceed those in plasma in the case of bile, prostatic fluid and tissue, saliva, sputum and vaginal secretions. Levels in the aqueous humor, breast milk, cerebrospinal fluid, middle ear fluid, synovial fluid and tissue (intestinal) fluid are adequate for antibacterial activity. Trimethoprim passes into amniotic fluid and foetal tissues reaching concentrations approximating those of maternal serum.</p><p style="text-align:justify">Approximately 66% of sulphamethoxazole in the plasma is protein bound.</p><p style="text-align:justify">The concentration of active sulphamethoxazole in amniotic fluid, aqueous humour, bile, cerebrospinal fluid, middle ear fluid, sputum, synovial fluid and tissue (interstitial) fluid is of the order of 20-50% of the plasma concentration.</p><p style="text-align:justify"><strong><u>Biotransformation</u></strong></p><p style="text-align:justify">Renal excretion of intact sulphamethoxazole accounts for 15-30% of the dose. This drug is more extensively metabolised than trimethoprim, via acetylation, oxidation or glucuronidation. Over a 72 hour period, approximately 85% of the dose can be accounted for in the urine as unchanged drug plus the major (N4-acetylated) metabolite.</p><p style="text-align:justify"><strong><u>Elimination</u></strong></p><p style="text-align:justify">The half-life of trimethoprim in man is in the range 8.6 to 17 hours in the presence of normal renal function. There appears to be no significant difference in the elderly compared with young patients.</p><p style="text-align:justify">The principle route of excretion of trimethoprim is renal and approximately 50% of the dose is excreted in the urine within 24 hours as unchanged drug. Several metabolites have been identified in the urine. Urinary concentration of trimethoprim varies widely.</p><p style="text-align:justify">The half-life of sulphamethoxazole in man is approximately 9-11 hours in the presence of normal renal function. There is no change in the half-life of active sulphamethoxazole with a reduction in renal function but there is prolongation of the half-life of the major, acetylated metabolite when the creatinine clearance is below 25 ml/minute.</p><p style="text-align:justify">The principle route of excretion of sulphamethoxazole is renal; between 15% and 30% of the dose recovered in the urine is in the active form.</p><p style="text-align:justify"><strong><u>Special patient populations</u></strong></p><p style="text-align:justify"><strong>Renal impairment</strong></p><p style="text-align:justify">The elimination half-life of trimethoprim is increased by a factor of 1.5-3.0 when the creatinine clearance is less than 10 mL/minute. When the creatinine clearance falls below 30 mL/min the dosage of co-trimoxazole should be reduced (see section 4.2).</p><p style="text-align:justify"><strong>Hepatic impairment</strong></p><p style="text-align:justify">Caution should be exercised when treating patients with severe hepatic impairment as there may be changes in the absorption and biotransformation of trimethoprim and sulphamethoxazole</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Older patients</strong></p><p style="text-align:justify">In older patients, a slight reduction in renal clearance of sulphamethoxazole but not trimethoprim has been observed.</p><p style="text-align:justify"><strong>Paediatric population</strong></p><p style="text-align:justify">The pharmacokinetics in the paediatric population with normal renal function of both components of suspension, trimethoprim and sulphamethoxazole are age dependent. Elimination of trimethoprim - sulphamethoxazole is reduced in neonates, during the first two months of life, thereafter both trimethoprim and sulphamethoxazole show a higher elimination with a higher body clearance and a shorter elimination half-life. The differences are most prominent in young infants (&gt; 1.7 months up to 24 months) and decrease with increasing age, as compared to young children (1 year up to 3.6 years), children (7.5 years and &lt; 10 years) and adults (see section 4.2).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:0cm; margin-right:0cm; text-align:justify">At doses generally in excess of recommended human therapeutic dose, trimethoprim and sulphamethoxazole have been reported to cause cleft palate and other foetal abnormalities in rats, findings typical of a folate antagonist. Effects with trimethoprim were preventable by co-administration of dietary folate. In rabbits, foetal loss was seen at doses of trimethoprim in excess of human therapeutic doses.</p><p style="margin-left:0cm; margin-right:0cm; text-align:justify">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table cellspacing="0" cellpadding="0" border="0" style="width:645px"><tbody><tr><td style="vertical-align:top"><table cellspacing="0" cellpadding="0" border="0" style="width:387.0pt"><tbody><tr><td style="vertical-align:top; width:387.0pt"><p style="text-align:justify"><strong><u>Inactive Ingredients:</u></strong></p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Glycerol</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Saccharin sodium</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Citric acid monohydrate</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Sucrose</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Tween 80</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Apricot flavour</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Banana flavour</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Raspberry red colour</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->FD&amp;C red 40</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->CMC sodium</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Aluminium magnesium silicate (veegum HV)</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Methyl paraben</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Propyl paraben</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Propylene glycol</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Sorbitol 70%</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Polyvinyl pyrrolidone (PVP-K-30)</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Colloidal silicon dioxide (Aerosil 200)</p></td></tr><tr><td style="vertical-align:top; width:387.0pt"><p style="margin-left:36.0pt; text-align:justify; text-indent:-23.4pt"><!--[if !supportLists]-->18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[endif]-->Purified water.</p></td></tr></tbody></table></td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top">&nbsp;</td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Trimol Suspension 50mL
Before opening: 24 months from the date of manufacturing
After opening: one month
Trimol Suspension 100mL 
Before opening: 48 months from the date of manufacturing
After opening: one month

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:9.0pt; margin-right:0cm; text-align:justify; text-indent:-9.0pt"><!--[if !supportLists]-->&sect; <!--[endif]-->Store below 30&ordm;C. After opening, use within one month.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:7.65pt; margin-right:0cm; text-align:justify; text-indent:-7.05pt"><!--[if !supportLists]-->&sect; <!--[endif]--><strong>Pack of 50mL:</strong> Suspension packed in an Amber coloured glass bottle provided with CRC cap, packed in a printed carton along with a leaflet.</p><p style="margin-left:7.65pt; margin-right:0cm; text-align:justify; text-indent:-7.05pt"><!--[if !supportLists]-->&sect; <!--[endif]--><strong>Pack of 100mL:</strong> Suspension packed in an Amber coloured glass bottle provided with CRC cap, packed in a printed carton along with a leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street
Ras Al Khaimah - United Arab Emirates
P.O. Box 997
Tel. No.:   (9717) 2 461 461
Fax No.:   (9717) 2 462 462

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                08. December. 2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>